failure to respond or late response
on 13 Oct 2020
Last Applicant/ Owned by
950 E. State Highway 114, Suite 160
Southlake
TX
76092
Serial Number
88292621 filed on 07th Feb 2019
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
dietary and nutritional supplements, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; ingredients for dietary and nutritional supplements, the primary purpose of which is to reduce inflammRead More
dietary and nutritional supplements, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; ingredients for dietary and nutritional supplements, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; dietary and nutritional supplements featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; topical creams, gels, salves, sprays, powders, oils, tinctures, balms and ointments, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; ingredients for topical creams, gels, salves, sprays, powders, oils, tinctures, balms and ointments, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; topical creams, gels, salves, sprays, powders, oils, tinctures, balms and ointments featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; pharmaceuticals, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; ingredients for pharmaceuticals, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; pharmaceuticals featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; dietetic foods, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; ingredients for dietetic foods, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; dietetic foods featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; dietetic beverages, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; ingredients for dietetic beverages, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; dietetic beverages featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; functional beverages, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; ingredients for functional beverages, the primary purpose of which is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease; functional beverages featuring an ingredient whose primary purpose is to reduce inflammation, relieve aches and pains, improve cognitive health, alleviate symptoms of attention deficit/hyperactivity disorder and post-traumatic stress disorder, improve overall health and reduce the risk of disease
No 88292621
No Service/Collective Mark
No 498181
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
13th Oct 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
13th Oct 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
24th Mar 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
24th Mar 2020 | FINAL REFUSAL E-MAILED |
24th Mar 2020 | FINAL REFUSAL WRITTEN |
11th Mar 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
11th Mar 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
11th Mar 2020 | ASSIGNED TO LIE |
05th Mar 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
12th Sep 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |